Chronic Lymphocytic Leukemia and Follicular Lymphoma | Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Chronic Lymphocytic Leukemia and Follicular Lymphoma

published 1 month ago by Dr Neil Love

Featuring perspectives from Dr Nathan H Fowler, Prof John G Gribben and Dr Brad S Kahl, including the following topics: Introduction (0:00) Choice of Front-Line Therapy for Chronic Lymphocytic Leukemia (CLL) (6:04) Selection of a BTK Inhibitor for the Treatment of CLL (20:11) Second-Line Therapy for CLL (27:50) Third-Line Therapy for CLL; Ongoing Research: Combination Strategies, Noncovalent BTK Inhibitors, CAR T-Cell Therapy (35:46) Selection of First- and Second-Line Treatment for Follicular Lymphoma (43:13) Third-Line Therapy for Follicular Lymphoma: Tazemetostat, PI3K Inhibitors, CAR T-Cell Therapy  (49:33) CME information and select publications

more episodes from Research To Practice | Oncology Videos